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Abstract 7 
The Type VI secretion system (T6SS) is protein nanomachine which is widespread in Gram-negative 8 
bacteria and used to translocate effector proteins directly into neighbouring cells. It represents a 9 
versatile bacterial weapon which can deliver effectors into distinct classes of target cells, playing key 10 
roles in inter-bacterial competition and bacterial interactions with eukaryotic cells. This versatility is 11 
underpinned by the ability of the T6SS to deliver a vast array of effector proteins, with many distinct 12 
activities and modes of interaction with the secretion machinery. Recent work has highlighted the 13 
importance and diversity of interactions mediated by T6SSs within polymicrobial communities and 14 
offered new molecular insights into effector delivery and action in target cells. 15 
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Introduction 20 
The Type VI secretion system (T6SS) is a protein nanomachine deployed by many Gram-negative 21 
bacteria in order to translocate effector proteins directly into target cells. Following its recognition 22 
as the sixth major protein secretion system in Gram-negative bacteria (Mougous et al., 2006; 23 
Pukatzki et al., 2006), the T6SS was initially believed to function as a classical virulence factor, 24 
namely to deliver effector proteins which destroy or manipulate the cells of eukaryotic host 25 
organisms (‘anti-eukaryotic T6SS’). However it has subsequently become clear that the primary 26 
function of the T6SS is as a device for inter-bacterial competion. In other words, bacteria use the 27 
T6SS to deliver toxic anti-bacterial effectors into rival bacterial cells (‘anti-bacterial T6SS’). More 28 
recently, the range of known uses of the T6SS has expanded further, including action against 29 
microbial fungi and scavenging of scarce metal ions. In parallel, recent work has revealed the 30 
importance of interactions mediated by anti-bacterial T6SSs in varied polymicrobial communities 31 
and offered new molecular insights into effector delivery and action in target cells. 32 
It has been estimated that > 25% of proteobacteria encode at least one T6SS in their genome (Bingle 33 
et al., 2008). These T6SSs, whilst sharing the same 13 or 14 core components (TssA-M, PAAR), show 34 
considerable variation in terms of gene content and function and can be split into six sub-families (1, 35 
2, 3, 4a, 4b, 5) (Barret et al., 2011; Boyer et al., 2009). Moreover, two further, evolutionarily-36 
divergent, T6SS-like systems have been reported. One is found on the Francisella pathogenicity 37 
island and designated T6SSii, the other is found in the phylum Bacteroidetes and designated T6SSiii, 38 
whilst the widespread and well-characterised proteobacterial T6SS can be termed T6SSi . T6SSii and 39 
T6SSiii have distinct components but a common overall mode of action when compared with the 40 
canonical T6SSi (Clemens et al., 2015; Russell et al., 2014). A given bacterial species can contain 41 
between one and six different T6SSs, with the complement of T6SSs present frequently varying 42 
between individual strains. In some bacteria, one T6SS is used for two distinct roles, e.g. the T6SS in 43 
Vibrio cholerae is both anti-bacterial and anti-eukaryotic (MacIntyre et al., 2010), whilst in other 44 
cases different T6SSs fulfil distinct roles, e.g. T6SS-5 and T6SS-1 in Burkholderia thailandensis have 45 
exclusively anti-host and anti-bacterial activity, respectively (Schwarz et al., 2010). In general, 46 
different bacterial species and strains use and tailor their T6SS(s) for specific roles according to the 47 
niche and strategy of the organism. In addition to variation in number and type of T6SS itself, there 48 
is also considerable diversity in effector portfolio. Furthermore, regulation of T6SS gene expression is 49 
highly organism-specific and matched with the biological role the system is required to fulfil. For 50 
example, the anti-host T6SS of B. mallei is regulated by the global virulence regulator VirAG, whilst 51 
the ‘defensive’ anti-bacterial H1-T6SS of Pseudomonas aeruginosa is post-transcriptionally activated 52 
by cell damage-derived signals via the RetS/Gac/Rsm pathway (LeRoux et al., 2015; Schell et al., 53 
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2007). The aim of this review is to showcase the diversity and breadth of functions mediated by the 54 
T6SS and highlight the widespread importance of this system in many contexts. 55 
Mechanism of effector delivery by the T6SS 56 
The T6SS is a large and dynamic ‘nanomachine’ that uses a contraction mechanism to propel an 57 
extracellular puncturing structure out of the secreting cell. The force of this propulsion can further 58 
drive the puncturing structure, which is decorated with effector proteins, into an immediately-59 
adjacent cell, thus achieving contact-dependent translocation of effector proteins into target cells 60 
(summarised in Figure 1). 61 
Assembly and firing of the T6SS machinery 62 
As reviewed in detail elsewhere (Brackmann et al., 2017; Cianfanelli et al., 2016b; Clemens et al., 63 
2018; Nguyen et al., 2018), the T6SS is an envelope-spanning apparatus assembled from 14 core 64 
components (TssA-M, PAAR) and comprising several distinct sub-assemblies: membrane complex, 65 
cytoplasmic baseplate, cytoplasmic contractile sheath and expelled puncturing structure. The 66 
puncturing structure consists of a tube of stacked hexameric rings of the Hcp (TssD) protein, topped 67 
by a spike made of a VgrG (TssI) trimer with a PAAR domain-containing protein tip. Assembly begins 68 
with the formation of the bell-shaped membrane complex, comprising ten or twelve copies each of 69 
the outer membrane protein TssJ and the inner membrane proteins TssLM (Durand et al., 2015; 70 
Nguyen et al., 2018). The cytoplasmic face of the membrane complex then docks the baseplate, 71 
which consists of six TssEF2G(K3)2 ‘wedges’ around a central VgrG3PAAR unit. TssK acts as a connector 72 
linking the baseplate to the membrane complex, by interacting with TssFG and the cytoplasmic 73 
domains of TssLM (Cherrak et al., 2018; Nazarov et al., 2018; Nguyen et al., 2018). The Hcp tube can 74 
then assemble onto the base of VgrG, extending into the cytoplasm. Simultaneously, a helical sheath 75 
structure made of TssBC subunits polymerises around the Hcp tube in an extended, high-energy 76 
‘primed’ conformation (Kudryashev et al., 2015; Renault et al., 2018; Wang et al., 2017). Rapid (< 2 77 
ms) contraction of the TssBC sheath drives the Hcp-VgrG-PAAR structure through the baseplate and 78 
membrane complex, out of the secreting cell. Contraction of the TssBC sheath, which can span the 79 
width of the producing cell, provides sufficient power and reach for the expelled Hcp-VgrG-PAAR 80 
structure to also breach an appropriately located recipient cell (Basler, 2015; Vettiger et al., 2017; 81 
Wang et al., 2017). Following contraction, the contracted sheath is specifically depolymerised by the 82 
ATPase TssH, whilst the effectors are somehow released inside the target cell. A role for the final 83 
core T6SS component, TssA, in capping the distal end of the Hcp-TssBC structure and co-ordinating 84 
assembly of the inner tube and the sheath has recently been described (Dix et al., 2018; Zoued et al., 85 
2016). 86 
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The contraction-based mechanism of the T6SS is related to the injection mechanism of contractile 87 
bacteriophages, with close structural similarities between the Hcp-VgrG-PAAR structure and the 88 
phage tail tube and tail spike, between the TssBC sheath and the tail sheath, and between the 89 
TssEFG and gp25gp62gp7 wedge units (Brackmann et al., 2017; Cherrak et al., 2018). However in 90 
contrast with the phage system, the T6SS can be reused for multiple firing events by the same cell. 91 
Indeed dynamic cycles of T6SS assembly-contraction-disassembly have been observed using 92 
fluorescence microscopy imaging of individual T6SSs in a number of organisms, including V. cholerae, 93 
enteroaggregative E. coli  (EAEC), P. aeruginosa and Serratia marcescens (Basler et al., 2012; Basler 94 
et al., 2013; Durand et al., 2015; Ostrowski et al., 2018).  95 
Accessory components 96 
In addition to the core components above, T6SSs are diversified and further tailored for their 97 
function by the possession of accessory structural or regulatory components which are present in 98 
some, but not all, T6SSs. In some systems an additional membrane complex component, SciZ/TagL, 99 
provides a peptidoglycan binding functionality normally present in TssL, whilst, conversely, T6SSs 100 
may also co-opt peptidoglycan hydrolase enzymes to assist in the formation of the membrane 101 
complex through the cell wall (Aschtgen et al., 2010; Santin & Cascales, 2017; Weber et al., 2016). In 102 
EAEC, a membrane-associated TssA-family protein, TagA, interacts with TssA in order to ‘catch’, stop 103 
and stabilise the extending TssBC sheath when it reaches the opposite side of the cell (Santin et al., 104 
2018). Although some other T6SSs possess a second TssA-family protein which is likely to function 105 
similarly, many do not, leaving open the question of how else this function might be achieved. 106 
Another protein, TagJ, may help to recruit TssH to the contracted sheath in some systems (Forster et 107 
al., 2014).  108 
 Many T6SSs also contain conserved post-translational regulatory components. In P. aeruginosa and 109 
S. marcescens, a membrane-bound protein threonine kinase, PpkA, phosphorylates the T6SS-110 
associated Fha protein, overcoming inhibition mediated by a negative regulator,TagF, and thereby 111 
allowing assembly of an active T6SS. An antagonistic phosphatase, PppA, promotes spatial relocation 112 
of the T6SS machinery between firing events. Interestingly, the two systems are used to increase the 113 
efficiency of T6SS anti-bacterial activity in distinct ways. In P. aeruginosa, the TagQRST complex 114 
detects incoming T6SS-mediated attacks from neighbouring cells, activating PpkA and thus causing 115 
the H1-T6SS to assemble and fire back towards the attacker, making it a ‘defensive’ system. In S. 116 
marcescens, the upstream regulator of PpkA is a distinct protein, RtkS, and the signal for activation is 117 
independent of incoming attack or cell-cell contact, resulting in an ‘offensive’ system which can 118 
attack passive or aggressive neighbours (Cianfanelli et al., 2016b; Ostrowski et al., 2018; and 119 
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references therein). Other variations also exist, including PpkA-mediated phosphorylation of TssL in 120 
A. tumefaciens (Lin et al., 2014). 121 
Modes of effector delivery   122 
An important aspect of the versatility of the T6SS is its ability to deliver a large variety of different 123 
types of effector proteins. To achieve this, effectors can associate with the expelled Hcp-VgrG-PAAR 124 
structure through multiple distinct mechanisms in order to be translocated between cells (Figure 1). 125 
‘Cargo’ effectors non-covalently interact with specific Hcp, VgrG or PAAR proteins, whilst 126 
‘specialised’ effectors comprise modular proteins in which additional effector domains are 127 
covalently fused to the C-terminus of Hcp, VgrG or PAAR proteins (Cianfanelli et al., 2016b; Durand 128 
et al., 2014). Hcp-dependent cargo effectors are relatively small, bind within the lumen of the Hcp 129 
hexamer and are recognised and stabilised by this interaction, as first described for the anti-bacterial 130 
effectors Tse2, Tse1 (Tae1PA) and Tse3 (Tge1 PA) of P. aeruginosa (Silverman et al., 2013). VgrG-131 
dependent cargo effectors interact with specific VgrG proteins to sit on the outside of the spike and 132 
include many phospholipase effectors, such as Tle1EC from EAEC (Flaugnatti et al., 2016). Examples of 133 
PAAR-interacting cargo effectors have also recently been reported, including TseT in P. aeruginosa 134 
(Burkinshaw et al., 2018). Many different examples of specialised VgrG effectors (also termed 135 
‘evolved VgrGs’) have been described, including VgrG-1 of V. cholerae, which possesses a C-terminal 136 
actin crosslinking domain (ACD) (Pukatzki et al., 2007). PAAR domain-containing specialised effectors 137 
are also widespread and diverse, including many nuclease toxins. They can be based simply on a 138 
PAAR domain followed by an effector domain, but also include a group of large polymorphic toxins 139 
known as Rhs proteins. In the latter, a conserved central Rhs repeat domain is predicted to form a 140 
shell-like structure around a C-terminal effector domain, with different Rhs proteins possessing a 141 
multitude of distinct C-terminal domains and associated immunity proteins (Alcoforado Diniz & 142 
Coulthurst, 2015; Hachani et al., 2014; Whitney et al., 2014; Zhang et al., 2012). It also appears that 143 
effector domains may on occasion be fused at the N-terminal end of PAAR proteins, further 144 
emphasizing their modularity (Shneider et al., 2013). A family of specialised Hcp effectors with a 145 
number of distinct C-terminal effector domains, present in members of the Enterobacteriaceae, has 146 
also recently been described (Ma et al., 2017a). Thus all three components of the expelled 147 
puncturing structure can be used for both cargo and specialised effector delivery modes. A given 148 
T6SS is typically associated with multiple VgrG, PAAR and/or Hcp homologues, with or without 149 
specialised effector domains, allowing for delivery of many effectors. Specific combinations of these 150 
homologues define functional tube-spike units and determine the effectors translocated by that 151 
firing event (Cianfanelli et al., 2016a). However the frequency and significance of the formation of 152 
VgrG heterotrimers, or of ‘mixed’ Hcp tubes, is currently unclear. 153 
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In some cases, effector recruitment and therefore delivery by the T6SS requires a further 154 
‘chaperone’ or ‘adaptor’ protein. Several unrelated but widespread families of such chaperones have 155 
been described to date. EagR/EagT (DUF1795) proteins bind the N-terminal PAAR-containing 156 
domains of Rhs and Tse6-like effectors, stabilising transmembrane regions which may ultimately 157 
permit the effectors to cross the recipient cell inner membrane and allowing the effector to be 158 
loaded onto the cognate VgrG (Cianfanelli et al., 2016a; Quentin et al., 2018). Tap-1/TecL (DUF4213) 159 
family proteins allow the interaction and loading of VgrG-dependent cargo effectors, including TseL 160 
and Tde1, onto the cognate VgrG. They are modular adaptors, where the C-terminal half of the 161 
protein varies with the associated effector, providing a mechanism for new effectors to be 162 
horizontally acquired and interact with existing VgrG homologues via recombination within the Tap-163 
1 gene (Ma et al., 2014; Unterweger et al., 2015). A chaperone (TecT) facilitating interaction of a 164 
PAAR-dependent cargo effector with the cognate PAAR protein has also been reported, with PAAR 165 
competing with a co-chaperone for access to the chaperone (Burkinshaw et al., 2018). None of these 166 
families of chaperones appear to be secreted with their effectors, rather their role is to protect and 167 
load specific effectors onto the machinery prior to secretion. Consistent with the different routes of 168 
effector secretion, there is no universal secretion signal for substrates of the T6SS. No such signal is 169 
required for specialised effectors, whilst cargo effectors require specific 3D interactions with their 170 
cognate VgrG/PAAR/Hcp protein, assisted in many cases by specific chaperones. One secretion motif 171 
(‘MIX’) has been identified in a subset of effectors widespread in Vibrionaceae (Salomon et al., 172 
2014); this motif is likely to define an adaptor domain interacting with one of the core components. 173 
Anti-bacterial effectors 174 
T6SSs represent widespread and potent weapons for killing or inhibiting rival bacterial cells, both 175 
within and between species. This is achieved by the delivery of broad-spectrum anti-bacterial 176 
effectors (Figure 2), with a given system typically able to deliver one or more representatives of 177 
several different effector families. 178 
Classes and modes of action of T6SS-delivered anti-bacterial effectors 179 
A large number of T6SS effectors which target the peptidoglycan cell wall of recipient bacteria have 180 
been identified. These peptidoglycan hydrolases can be divided into at least five families of 181 
peptidoglycan amidases (Tae1-4, TaeX), which cleave specific bonds within the peptide cross-bridges 182 
of the cell wall, and four families of peptidoglycan glycoside hydrolases (Tge1-3, VgrG-3), which 183 
cleave the backbone glycan chains (Brooks et al., 2013; Ma et al., 2018; Russell et al., 2012; Whitney 184 
et al., 2013). The inner membrane is also a common target of T6SS effectors. Five families of 185 
lipase/phospholipase effector (Tle1-4, includes effectors with phospholipase A1 or A2 activity, and 186 
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Tle5, phospholipase D) have been described (Flaugnatti et al., 2016; Russell et al., 2013). Additionally 187 
two effectors, VasX and Tse4, have been reported to form pores or channels in the membrane 188 
(LaCourse et al., 2018; Miyata et al., 2013). All these effectors targeting the cell wall or membrane 189 
act in/from the periplasm, being generally non-toxic if expressed in the cytoplasm and in some cases 190 
activated by periplasmic insertion of disulphide bonds (Mariano et al., 2018). This suggests that the 191 
major destination for incoming effectors is likely to be the periplasm of target cells, which may also 192 
inform on why the T6SS does not appear to act against Gram-positive cells which lack this 193 
compartment. However T6SSs also deliver effectors which act in the bacterial cytoplasm. A number 194 
of T6SS-dependent nuclease effectors have also been described (e.g. DNases Tde1 and RhsAB) with 195 
many more, particularly PAAR-containing specialised effectors, predicted to possess DNase, RNase 196 
or deaminase activity according to bioinformatic analyses (Koskiniemi et al., 2013; Ma et al., 2017b; 197 
Ma et al., 2014; Zhang et al., 2012). T6SS effectors can also act by degrading an essential cytoplasmic 198 
cofactor, as revealed by the identification of two families of NAD(P)+ hydrolase effectors (Tse6/Tne1 199 
and Tne2) (Tang et al., 2018; Whitney et al., 2015). Recently a T6SS-delivered ADP-ribosyltransferase 200 
toxin, Tre1, which modifies FtsZ by the addition of ADP-ribose and thus inhibits cell division, has 201 
been described. Such toxins are often used by bacteria against eukaryotic cells but this work 202 
suggests they may also be used by several inter-bacterial toxin delivery systems including the T6SS 203 
(Ting et al., 2018). Cytoplasmic acting effectors may reach the cytoplasm in several ways: by a 204 
minority of T6SS delivery events reaching the cytoplasm directly, by effectors incorporating 205 
transmembrane domains to allow their own traversal of the inner membrane, and/or by target cell 206 
protein-mediated import similar to Cdi toxins; to date, some evidence has been presented for each 207 
possibility (Quentin et al., 2018; Vettiger & Basler, 2016; Whitney et al., 2015; Willett et al., 2015). 208 
Whilst numerous and varied T6SS-dependent antibacterial effectors have already been reported, it 209 
seems clear that the portfolio of effectors and of effector modes of action will continue to grow, 210 
given that many effectors identified to date still have no known or readily-predictable function and 211 
that new effectors will be revealed by experimental and bioinformatic analysis of increasing 212 
numbers of bacterial strains and species.  213 
Self-protection by specific immunity proteins 214 
Any bacterial cell possessing an anti-bacterial T6SS must possess a means to prevent self-intoxication 215 
by its own effectors (cytoplasmic-acting effectors, prior to secretion) and intoxication by effectors 216 
delivered into it by its neighbouring sibling cells (all effectors, incoming). This is achieved through 217 
specific immunity proteins, which are encoded adjacent to the gene for the cognate effector protein. 218 
Immunity proteins reside in the cellular compartment of action of the effector and normally bind 219 
tightly to the effector to physically prevent toxicity (Figure 2) (Alcoforado Diniz & Coulthurst, 2015). 220 
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For example, immunity proteins against peptidoglycan hydrolase effectors are soluble or lipid-221 
anchored periplasmic proteins which specifically bind to their cognate effectors and block the active 222 
site (Russell et al., 2011; Srikannathasan et al., 2013; Whitney et al., 2013). Interestingly, the Tri1 223 
immunity protein, which protects against the Tre1 ADP-ribosyltransferase effector, has a novel dual 224 
function. In addition to a typical, specific active site occlusion mechanism, it also has an enzymatic 225 
ADP-ribosylhydrolase activity which removes the modification added by the effector and confers 226 
broad resistance to related toxins (Ting et al., 2018). 227 
Evolution and acquisition of effector-immunity pairs 228 
T6SS-mediated inter-bacterial competition occurs between and within bacterial species, mediated 229 
by considerable variation in effector-immunity portfolio, even between strains of the same species. 230 
In addition to diversity in the number and type of effector, there is also variation within effector 231 
families, resulting in related but specific and mutually-incompatible effector-immunity pairs. In 232 
general, effector-immunity pairs appear to be horizontally acquired in an inter-bacterial ‘arms race’. 233 
In the case of specialised effectors, there is some evidence, particularly for Rhs proteins, that 234 
homologous recombination events allow the facile exchange of one C-terminal effector domain plus 235 
cognate downstream immunity gene for another pair, resulting in highly variable loci which can 236 
mediate competition between strains (Koskiniemi et al., 2014). For cargo effectors, whilst simple 237 
effector-immunity pairs can be acquired, it appears that they are often acquired together with linked 238 
chaperone or VgrG proteins which are predicted to allow their delivery in the recipient background 239 
(Barret et al., 2011; Fitzsimons et al., 2018; Unterweger et al., 2015). So-called ‘orphan’ immunity 240 
proteins, which do not confer resistance to effectors currently possessed by the organism, are 241 
frequently encoded downstream of a related ‘active’ effector-immunity pair. They may be retained 242 
from formerly-active effector-immunity pairs where the effector has been lost, or represent newly-243 
acquired genes, in both cases likely able to confer protection against effectors delivered by other 244 
strains (Alcoforado Diniz et al., 2015; Kirchberger et al., 2017). Many T6SS effectors appear to be 245 
modular toxin domains which can be used for inter-bacterial competition in several contexts, such as 246 
as cargo or specialised T6SS effectors, effectors delivered by contact-dependent inhibition (Cdi) or 247 
Type VII (ESAT/Esx) secretion systems, or toxin domains of colicins. For example, Tne2 domains are 248 
found in putative T6SS cargo effectors, in Rhs and smaller PAAR specialised T6SS effectors, and in 249 
proteins containing LXG and WXG motifs associated with T7SSs (Tang et al., 2018), whilst CdiA toxin 250 
domains are frequently shared with T6SS-associated Rhs proteins and can also be found in putative 251 
T6SS cargo effectors (Batot et al., 2017; Poole et al., 2011).  252 
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One reason why anti-bacterial T6SSs are so effective is likely to be because multiple distinct effectors 253 
can be delivered at the same time. One one hand, this means that a rival cell cannot simply protect 254 
itself by becoming spontaneously resistant to one effector or acquiring one immunity protein. 255 
Perhaps more importantly, simultaneous delivery of effectors targeting the cell wall, cell membrane 256 
and cellular DNA, for example, or attacking one target with several different enzymatic activities, is 257 
likely to lead to more efficient killing than any effector alone. Indeed synergy between several 258 
different combinations of effectors has been demonstrated in P. aeruginosa (LaCourse et al., 2018). 259 
This study also suggested that multiple effectors may protect against variations in environmental 260 
conditions which might reduce the efficacy of an individual toxin. 261 
Roles of anti-bacterial T6SSs in bacterial communities 262 
The killing activity conferred by anti-bacterial T6SSs can be extremely potent during in vitro co-263 
culture experiments, with T6SS-wielding cells often able to virtually eliminate similar numbers of 264 
susceptible competitor cells within a few hours. The obvious next question, then, is how that activity 265 
is used and relevant in ‘real-life’ microbial communities and niches. Once T6SS-dependent anti-266 
bacterial activity had been identified (Hood et al., 2010), it became clear that reports of virulence 267 
defects in T6SS mutants should be carefully evaluated, since decreased fitness of a T6SS mutant 268 
could be due to loss of ability to compete against the resident microbiota or co-infecting pathogens, 269 
rather than the T6SS having a direct effect on host cells. Some years on, there is now evidence that 270 
anti-bacterial T6SSs can markedly influence the composition of host-associated communities and 271 
affect the outcome for the host. Anti-bacterial T6SSs can also play roles in the social behaviour of 272 
bacteria, for example recognition of self, and facilitate horizontal gene transfer by releasing DNA 273 
from prey cells. 274 
Polybacterial host-associated communities 275 
A number of studies have demonstrated a role for anti-bacterial T6SSs in overcoming colonisation 276 
resistance of the gut microbiota towards pathogens. The T6SS of Salmonella typhimurium was found 277 
to be required for successful establishment of infection in the gut if the resident microbial 278 
community was intact, whilst the T6SS of Shigella sonnei increased its ability to outcompete 279 
commensal E. coli and persist in a mouse model (Anderson et al., 2017; Sana et al., 2016). In V. 280 
cholerae, T6SS-mediated anti-bacterial activity against the host commensal microbiota was shown to 281 
increase intestinal colonisation and activate host innate immunity genes in an infant mouse model, 282 
and to contribute to colonisation of the middle small intestine in the infant rabbit model (Fu et al., 283 
2018; Zhao et al., 2018). Interestingly, in a Drosophila infection model, T6SS-mediated killing of a 284 
subpopulation of commensal bacteria was somehow actively required to trigger host destruction by 285 
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V. cholerae (Fast et al., 2018). In contrast, in a zebrafish model, removal of a pre-colonised symbiotic 286 
species from the gut in a manner dependent on the action of the V. cholerae T6SS was not due to 287 
anti-bacterial activity, but rather a direct impact of the VgrG-1 ACD on host intestinal movements, 288 
emphasizing the potential complexities of T6SS-dependent in vivo interactions (Logan et al., 2018). 289 
Members of the Bacteroidales are major constituents of the human gut microbiota and commonly 290 
possess up to three distinct architectures of T6SSiii, with T6SS loci frequently transferred among co-291 
resident species in the gut (Coyne et al., 2016). T6SS-mediated competition has been observed 292 
between strains of B. fragilis in vivo and appears to play a key role in establishing a stable 293 
community of compatible Bacteriodes strains in a given individual (Chatzidaki-Livanis et al., 2016; 294 
Verster et al., 2017; Wexler et al., 2016). Anti-bacterial T6SS activity has also been implicated in 295 
generating colonisation resistance. A symbiotic B. fragilis strain was shown to utilise its T6SS and the 296 
effector Bte2 to exclude a pathogen, a toxigenic strain of B. fragilis, in vivo, protecting the host from 297 
colitis (Hecht et al., 2016). It will be interesting to see whether Bacteroides also utilise the T6SS 298 
against invading proteobacterial gut pathogens in vivo. In the bee gut, competition mediated by anti-299 
bacterial T6SSs, and in particular highly diverse and readily exchangeable Rhs effector domains, 300 
appears to be an important driver of fitness and evolution within the microbiota (Steele et al., 2017). 301 
Complex polymicrobial communities are also found associated with plant hosts, in particular within 302 
the rhizosphere. Anti-bacterial T6SSs are frequently found in both pathogenic and symbiotic or 303 
beneficial plant-associated bacteria (Bernal et al., 2018). This suggests that anti-bacterial T6SSs 304 
should be involved in establishing and protecting beneficial plant-associated communities and in 305 
invasion of these communities by pathogens. In support of this concept, T6SS-dependent anti-306 
bacterial activity in  the plant-protecting rhizosphere bacterium P. putida was shown to reduce 307 
colonisation and necrosis caused by the phytopathogen Xanthomonas campestris when co-308 
infiltrated into Nicotiana leaves (Bernal et al., 2017). From the other side, the anti-bacterial T6SS of 309 
the plant pathogen A. tumefaciens is effective against P. aeruginosa within a plant but not on lab 310 
media (Ma et al., 2014).  311 
A very specific symbiotic relationship is that between the Euprymna scolopes squid and V. fischeri, in 312 
which the bacteria colonise individual crypts in the squid light organ and ultimately bioluminesce. It 313 
turns out that an anti-bacterial T6SS plays a key role in selecting and spatially separating strains of V. 314 
fischeri colonising the light organ. Individual crypts cannot be colonised by two or more incompatible 315 
strains, where incompatibility is conferred by a difference in T6SS and effector-immunity 316 
complement (Speare et al., 2018). In general, host-associated bacterial communities typically exist in 317 
a biofilm state, where aggregates of cells are adhered to a surface within a polymeric extracellular 318 
matrix. This scenario is likely to be conducive to T6SS-dependent interactions, and indeed T6SS 319 
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genes are frequently co-regulated with biofilm genes and the T6SS has been shown to allow 320 
persistence of Burkholderia in a mixed biofilm (Schwarz et al., 2010). On the other hand, it has been 321 
suggested that extracellular polysaccharide may, in some cases, provide a physical barrier which 322 
reduces the effectiveness of T6SS attacks (Toska et al., 2018).  323 
Social behaviour and acquisition of genetic material 324 
Anti-bacterial T6SSs can represent a means by which one individual strain or genotype can 325 
distinguish self from non-self (i.e. from closely related strains). In some cases, this manifests as the 326 
formation of a boundary between two populations. In Proteus mirabilis, the formation of Dienes 327 
lines, macroscopic boundaries between swarms of two non-identical strains, is dependent on T6SS-328 
mediated killing of non-siblings via strain-specific effector-immunity pairs (Alteri et al., 2013; 329 
Wenren et al., 2013). Similarly, in Myxococcus xanthus, delivery of a T6SS nuclease toxin was shown 330 
to be required for the inability of colonies of different strains to merge (Gong et al., 2018). The T6SS 331 
has also been proposed to be a means of policing quorum sensing (QS) ‘cheats’, spontaneous QS 332 
mutants which benefit from the production of common goods (e.g. extracellular enzymes) by a 333 
population, whilst no longer producing the goods themselves. In B. thailandensis, QS activation of 334 
effector-immunity gene expression was shown to result in QS mutant cheats being eliminated by QS-335 
proficient cells intoxicating them with effectors they are no longer immune to (Majerczyk et al., 336 
2016). Even within a genetically uniform population, anti-bacterial T6SSs may be able to promote 337 
phenotypic homogeneity by allowing fitter cells to eliminate starving or otherwise less-fit cells from 338 
the population. Somewhat similar to elimination of QS cheats, starving cells of M. xanthus have 339 
reduced levels of T6SS and TsxI immunity proteins, allowing them to be killed by delivery of the TsxE 340 
effector by healthy neighbouring cells (Troselj et al., 2018). Mathematical modelling has provided 341 
support for the idea that T6SS-mediated inter-bacterial competition can lead to spatial separation of 342 
non-identical bacterial populations and suggested that this separation can favour the evolution of 343 
co-operation within the segregated population (McNally et al., 2017). 344 
A distinct ecological role for anti-bacterial T6SSs is in facilitating DNA uptake, and thus horizontal 345 
gene transfer, in naturally competent bacteria. T6SS-mediated lysis of non-self cells, whether closely 346 
or more distantly related, results in release of DNA from the targeted cell which can then be taken 347 
up by the T6SS-wielding attacker. This role was first identified in V. cholerae, where T6SS gene 348 
expression is co-regulated with that of the competence machinery (Borgeaud et al., 2015). Further 349 
studies in this organism indicated that T6SS effector-immunity genes themselves can be transferred 350 
in this way, thus an attacker can acquire new weapons from its prey (Thomas et al., 2017). Similarly, 351 
T6SS-mediated horizontal gene acquisition has been demonstrated in Acinetobacter (Cooper et al., 352 
12 
 
2017; Ringel et al., 2017). Transfer of genetic material from prey E. coli to Acinetobacter was 353 
frequent enough to allow observation of functional transformation in real time, which may help to 354 
explain why Acinetobacter baumannii is able to acquire antibiotic resistance so rapidly in the clinic 355 
(Cooper et al., 2017). 356 
Anti-host T6SS effectors 357 
In addition to widespread and versatile utilisation of anti-bacterial T6SSs, bacteria can also use T6SSs 358 
to directly target eukaryotic cells, including those of host organisms. There have been many reports 359 
of virulence, host response and host cell interaction phenotypes dependent on a functional T6SS, in 360 
a range of bacterial pathogens (Hachani et al., 2016). However given the caveat that such 361 
phenotypes may be an indirect result of the action of an anti-bacterial T6SS, for example against the 362 
host microbiota, it is pertinent to consider only those cases where T6SS effectors responsible for 363 
direct action against host cells have been identified. During the first decade of T6SS research, these 364 
were few in number: VgrG proteins with C-terminal actin crosslinking, actin ADP ribosylase and host 365 
membrane fusion domains; another VgrG protein with a tubulin binding domain which modulates 366 
microtubule-mediated bacterial internalisation; and two cargo phospholipase D effectors which also 367 
facilitate internalisation by binding Akt and activating the PI3K pathway; all reviewed by Hachani and 368 
coworkers (Hachani et al., 2016). These phospholipase effectors, PldA and PldB of P. aeruginosa, are 369 
also anti-bacterial effectors (Tle5 family) which exert toxicity from the periplasm of target cells 370 
lacking the cognate immunity proteins. This highlights another aspect of the versatility of the T6SS: 371 
not only is the same system sometimes able to deliver dedicated anti-eukaryotic and anti-bacterial 372 
effectors (e.g. the ACD-containing VgrG-1 and peptidoglycan hydrolase-containing VgrG-3 proteins 373 
delivered by the V. cholerae T6SS), but some effectors are able to act trans-kingdom, against both 374 
eukaryotic and prokaryotic cells (Brooks et al., 2013; Jiang et al., 2014).  375 
More recently, a number of other anti-host effectors have been reported. The T6SS of Francisella 376 
tularensis is required for virulence and intracellular proliferation, via phagosomal escape into the 377 
cytoplasm. Four effectors, PdpCD and OpiAB, delivered by this system and contributing to 378 
intramacrophage growth have been identified. PdpC is the major determinant of phagosomal 379 
escape, whilst OpiA can assist in this process through its PI(3)-kinase activity (Brodmann et al., 2017; 380 
Eshraghi et al., 2016; Ledvina et al., 2018). One of the first T6SS effectors identified, EvpP of 381 
Edwardsiella tarda, was recently shown to prevent activation of the NLRP3 inflammasome by 382 
inhibiting the Ca2+-dependent MAPK-Jnk pathway, whilst TecA of B. cenocepacia was shown to cause 383 
activation of the Pyrin inflammasome via its Rho GTPase deaminase activity and the resulting 384 
cytoskeleton disruption (Figure 3) (Aubert et al., 2016; Chen et al., 2017). Actin rearrangement is 385 
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also induced by a CNF1-like toxin delivered by V. parahaemolyticus, whilst a Tle4-family 386 
phospholipase of P. aeruginosa causes disruption of the endoplasmic reticulum (Jiang et al., 2016; 387 
Ray et al., 2017). In addition, a catalase effector from EHEC, KatN, was proposed to act against 388 
reactive oxygen species within host cells (Wan et al., 2017). 389 
The T6SS as a weapon against eukaryotic microbial competitors 390 
It is clear from the studies described in the previous section that the bacterial T6SS is able to deploy 391 
effector proteins against eukaryotic cells, and it is also well-appreciated that many polymicrobial 392 
communities, including those relevant clinically, contain both bacteria and fungi (Peleg et al., 2010). 393 
Therefore it is perhaps not surprising that the versatility of the T6SS extends to its use against fungal 394 
cells. Early indications that this could be the case came from observations of T6SS-dependent 395 
inhibition of the yeast Cryptococcus carnescens by the phytopathogen P. syringae and an increase in 396 
T6SS gene expression in a biocontrol strain of P. fluorescens when colonising plant roots in the 397 
presence of the fungal phytopathogen Gaeumannomyces graminis (Haapalainen et al., 2012; Marchi 398 
et al., 2013). Recently, the T6SS of S. marcescens, previously believed to be exclusively an anti-399 
bacterial T6SS, was shown to possess anti-fungal activity against Sacchromyces cerevisiae and 400 
Candida spp., and it was by studying this system that the first T6SS-delivered anti-fungal effector 401 
proteins were identified. These effectors, Tfe1 and Tfe2, have distinct actions against target fungal 402 
cells, ultimately leading to fungal cell death. Tfe1-mediated intoxication leads to plasma membrane 403 
depolarisation without the formation of aspecific pores, whilst Tfe2 intoxication disrupts nutrient 404 
uptake and amino acid metabolism and leads to the induction of autophagy, probably as a starvation 405 
reponse (Figure 3) (Trunk et al., 2018). Tfe1 and Tfe2 represent new classes of effector proteins, 406 
with no obvious similarity to other effectors or proteins of known function, and their precise mode 407 
of action remains to be elucidated. It is likely that T6SS-dependent anti-fungal activity is widespread. 408 
Not only can homologues of Tfe1 and Tfe2 be detected in other T6SS-wielding bacteria, but typical 409 
T6SS effector identification criteria are likely to miss anti-fungal effectors. These criteria include (1) 410 
association with T6SS genes, (2) anti-bacterial activity and adjacently-encoded immunity protein, 411 
and/or (3) the presence of known toxin or effector domains, all of which would have excluded Tfe1 412 
and Tfe2. This highlights the importance of unbiased approaches such as secretomics for the 413 
identification of new effectors. The discovery of T6SS-dependent anti-fungal activity suggests that 414 
the contribution of the T6SS to shaping polymicrobial communities is broader and more important 415 
than previously appreciated. Extending this idea further, there is also evidence that the T6SS can 416 
also act against other single-celled eukaryotes, namely amoebae. Indeed the T6SS was first identified 417 
through the requirement for an intact T6SS for V. cholerae to resist predation by Dictyostelium 418 
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discoideum (Pukatzki et al., 2006). Further work revealed that the pore-forming effector VasX and 419 
the actin crosslinking effector VgrG-1 are required for virulence against Dictyostelium, in addition to 420 
having anti-bacterial activity or anti-host activity, respectively (Miyata et al., 2011; Zheng et al., 421 
2011). Thus the V. cholerae T6SS can be utilised against bacterial competitors in the host or 422 
environment, against amoebal predators in the environment, and against the host directly, 423 
representing a truly versatile and multi-purpose weapon. 424 
A contact-independent role for T6SS in metal uptake 425 
A further role for the T6SS, this time not requiring effector delivery into target cells, has also been 426 
described. In this case, the T6SS is responsible for secretion of effectors to the extracellular milieu 427 
which allow the bacteria to take up particular metal ions. In Yersinia pseudotuberculosis, T6SS-4 428 
secretes a Zn2+-binding protein, YezP, under conditions of oxidative stress. Secreted YezP is proposed 429 
to scavenge Zn2+ ions and thus contribute to survival in the presence of reactive oxygen species 430 
produced by the host (Wang et al., 2015). Similarly, B. thailandensis T6SS-4 secretes a related Zn2+-431 
binding effector, TseZ, which allows Zn2+ uptake under conditions of oxidative stress via interaction 432 
of extracellular TseZ with the TonB-dependent outer membrane haem receptor HmuR (Si et al., 433 
2017a). The B. thailandensis T6SS-4 is also responsible for the secretion of another metallophore 434 
effector, TseM. TseM is required for manganese uptake under conditions of oxidative stress and 435 
interacts with MnoT, another TonB-dependent outer membrane receptor, to achieve transport of 436 
Mn2+ into the cell (Figure 3) (Si et al., 2017b). Importantly, it was demonstrated that possession of 437 
TseZ/HmuR or TseM/MnoT, and T6SS-4, by B. thailandensis provides a competitive advantage 438 
against other bacteria during co-culture in conditions where the respective metal ion is limiting but 439 
cells are not in contact. Thus T6SS-dependent secretion of metallophores to the media allows the 440 
producing organism to effectively scavenge scarce metal ions from the environment and thus 441 
outcompete bacterial competitors without directly harming them. Both metal uptake systems were 442 
also required for full virulence in a Galleria model, indicating an important role in metal acquisition 443 
within a host environment (Si et al., 2017a; Si et al., 2017b). It is not yet clear whether T6SS-4 in B. 444 
thailandensis and Y. pseudotuberculosis, and related systems in other organisms, are also used to 445 
deliver toxic effector proteins into target cells, or whether they are used exclusively for 446 
metallophore secretion; certainly their transcriptional regulation, responsive to oxidative stress and 447 
metal limitation, appears to be tailored for a metal scavenging function. 448 
A distinct role for a T6SS effector in metal uptake has been reported for the P. aeruginosa H3-T6SS-449 
dependent effector TseF. Extracellular TseF binds PQS-Fe2+ complexes incorporated within outer 450 
membrane vesicles (OMVs). (PQS, Pseudomonas Quinolone Signal, is a quorum sensing signalling 451 
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molecule with iron chelating properties.) TseF also interacts with the outer membrane siderophore 452 
receptor FptA and porin OprF and is proposed to mediate Fe2+ uptake by delivering OMV-associated 453 
PQS-Fe2+ to these receptors for transport into the cell (Lin et al., 2017). It is currently unclear why 454 
TseF or the metallophores above would be secreted by the T6SS, a system normally considered to be 455 
designed for effector translocation into cells. Nevertheless, these effectors once again highlight the 456 
breadth and versatility of T6SS function, as well as raising the possibility that other proteins that 457 
function extracellularly may utilise the T6SS for their secretion. 458 
Concluding Remarks 459 
It is now clear that the bacterial T6SS is used for an impressively broad range of functions, all linked 460 
by the purpose of increasing the competitive fitness of the secreting cell. While anti-host T6SSs allow 461 
the bacterium to compete with host defence mechanisms, anti-bacterial and anti-fungal T6SSs allow 462 
the bacterium to compete with rival microbes, both closely and distantly related. Furthermore, 463 
those T6SSs and effectors used for contact-independent metal scavenging allow the secreting 464 
bacterium to compete with both host defences and co-resident microbes. This functional versatility 465 
is permitted by an ever-growing repertoire of diverse effector proteins, and the ability to hook them 466 
up to the delivery device in many different ways. It is likely that the portfolio of known effector 467 
proteins will continue to increase rapidly, particularly given the evolutionary pressures of inter-468 
bacterial competition and the recent realisation that effectors may also have non-toxic extracellular 469 
roles. The extent of T6SS-related contributions to myriad bacterial interactions has further expanded 470 
by the validated inclusion of T6SSii (Francisella) and T6SSiii (Bacteriodetes) alongside the canonical 471 
T6SSi systems, with an even more distantly-related T6SS-like system (‘T6SSiv’) recently described 472 
(Bock et al., 2017). Importantly, recent work has not only revealed new molecular and atomic-level 473 
details of the mechanism of this intriguing machinery, but it has also begun to demonstrate the 474 
importance of T6SS-mediated cell-cell interactions in a variety of ‘real-life’, or at least relevant 475 
model, communities. It is likely that the future will reveal many more examples of communities 476 
whose composition, dynamics and proporties will be shaped by T6SSs of several flavours. Finally, it is 477 
exciting to note that T6SS could provide several potential opportunities for the development of new 478 
antimicrobial strategies. It might be possible to inhibit the T6SS itself to reduce the fitness of a T6SS-479 
wielding pathogen, although the broad distribution of the system in other bacteria including 480 
commensals would require consideration of specificity. Another avenue, although with similar issues 481 
when considering complex communities, could be generating engineered ‘biocontrol’ strains to 482 
target pathogens of concern. Finally, by studying T6SS effectors and the impact that they have on 483 
target cells, we may learn more about the basic physiology of host, bacterial or fungal cells and how 484 
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to effectively inhibit them. From both a fundamental and translational point of view, exciting times 485 
lie ahead regarding this versatile, widespread and effective bacterial nanoweapon. 486 
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Figure 1. Effector delivery by the Type VI Secretion system of a Gram-negative bacterium.  
Schematic illustration of the current model for the contraction-based ‘firing’ mechanism of the T6SS. 
The T6SS assembles with the contractile TssBC sheath in an ‘extended’ conformation. Contraction of 
this sheath, which is anchored to a cytoplasmic baseplate docked on an envelope-spanning 
membrane complex, drives the Hcp-VgrG-PAAR puncturing structure out of the cell. An adjacent 
target cell can also be breached by this tube-spike structure. Following contraction, TssH 
depolymerises the contracted sheath and the T6SS disassembles at least partially, ready for a new 
round of firing. The insets illustrate the different ways in which effectors can interact with the 
expelled Hcp-VgrG-PAAR puncturing structure in order to be translocated out of the secreting cell 
and into a target cell. ‘Cargo’ effectors non-covalently interact with Hcp, VgrG or PAAR proteins, 
whilst ‘specialised’ effectors consist of an effector domain covalently fused to a VgrG or Hcp protein 
or a protein containing a PAAR-repeat containing domain. For further details, see the text.  
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Figure 2. Anti-bacterial effectors and cognate immunity proteins. 
Schematic illustration of modes of action of T6SS-delivered anti-bacterial effector proteins and their 
neutralisation by self-protecting immunity proteins. The T6SS can deliver a variety of toxic effector 
proteins into a target cell, which may act on different cellular targets including the peptidoglycan cell 
wall, cellular nucleic acids and the inner membrane. Immunity proteins specific for each individual 
effector are localised at the site of action of their cognate effector and typically neutralise the toxin 
by direct binding and physical inhibition. Immunity proteins protect the secreting cell from its own 
toxins prior to secretion, if they act in the cytoplasm and are not shielded by another structure such 
as an Rhs repeat domain (this possibility is not depicted here). Immunity proteins also protect 
genetically identical cells from the action of all the effectors delivered by their neighbouring sibling. 
Note that only one PAAR-containing protein and one VgrG trimer can be delivered in a single firing 
event, although several are included here for illustrative purposes. PG, peptidoglycan. 
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Figure 3. Examples of Type VI secreted effectors with roles distinct from anti-bacterial toxins. 
Schematic illustration of current models for the action of the anti-host effector TecA (a), anti-fungal 
effectors Tfe1 and Tfe2 (b), and metallophore effector TseM (c). (a) B. cenocepacia delivers TecA 
from within the B. cenocepacia containing vacuole (BcCV), causing deamidation of specific 
asparagine residues in Rho family GTPases RhoA and Rac1, leading to disruption of the actin 
cytoskeleton, activation of the pyrin inflammasome and pyroptosis and increasing bacterial 
clearance (Aubert et al., 2016). (b) S. marcescens delivers Tfe1 and Tfe2 into fungal cells, including C. 
albicans and S. cerevisiae. The action of Tfe1 leads to depolarisation of the fungal plasma membrane 
without  formation of large aspecific pores. The action of Tfe2 disrupts inter-related pathways 
involved in sulfate assimilation, plasma membrane nutrient transport and amino acid metabolism, 
leading to a starvation response including induction of autophagy. Intoxication by Tfe1 and Tfe2 can 
eventually cause cell death (Trunk et al., 2018). (c) B. thailandensis uses its T6SS-4 to translocate 
TseM to the extracellular milieu, where it binds Mn2+. TseM loaded with Mn2+ interacts with the 
outer membrane TonB-dependent receptor MnoT, which is associated with a TonB-ExbD-ExbB 
complex, transferring Mn2+ from TseM to MnoT and allowing its active import across the outer 
membrane. Either the SitABCD or MntH transporters may then be utilised to import Mn2+ across the 
inner membrane (Si et al., 2017b). 
